According to the latest report by IMARC Group, titled Endocrine Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028, offers a comprehensive analysis of the industry, which comprises insights onendocrine testing market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global endocrine testing market size reached US$ 10.4 Billion in 2022. Looking forward, IMARC Group expects themarket to reach US$ 16.4 Billion by 2028, exhibiting a growth rate (CAGR) of 7.7% during 2023-2028.
What isendocrine testing?
Endocrine testing is a medical diagnostic process that examines the function of the endocrine system, which regulates the production and secretion of hormones in the body. The endocrine system maintains many important functions, including metabolism, growth and development, and sexual function. Endocrine testing involves various tests, including blood, urine, and saliva, and imaging studies, such as ultrasound and MRI scans. These tests can help diagnose endocrine disorders such as diabetes, thyroid disease, and adrenal gland disorders. It is important for diagnosing and managing a range of medical conditions. It can help identify hormonal imbalances and guide appropriate treatment, including hormone replacement therapy or medication. It can also be used to monitor the effectiveness of treatments over time.
Get a Sample Copy of this Report:https://www.imarcgroup.com/endocrine-testing-market/requestsample
What are the growth prospects and trends in the endocrine testing industry?
The global market is majorly driven by the growing prevalence of endocrine disorders such as diabetes, thyroid disease, and adrenal gland disorders. In line with this, the advancements in diagnostic technologies such as immunoassays and chromatography are significantly contributing to the market. Furthermore, the aging population, which is more susceptible to endocrine disorders, is positively influencing the market. Apart from this, the rising awareness about the importance of early diagnosis and treatment of endocrine disorders is catalyzing the demand for endocrine testing. Moreover, the growing demand for personalized medicine and the development of minimally invasive methods are propelling the market. Besides, the escalating healthcare expenditure and the rapid adoption of point-of-care testing are strengthening the market. Additionally, the government's worldwide initiatives to promote early diagnosis and treatment of endocrine disorders are driving the demand for endocrine testing.
Browse Full Report with Charts, Table of contents, and List of Figures:https://www.imarcgroup.com/endocrine-testing-market
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Abbott Laboratories
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- BioMerieux SA
- DiaSorin S.p.A.
- Hoffmann-La Roche AG (Roche Holding AG)
- Laboratory Corporation of America Holdings
- Quest Diagnostics Incorporated
- Thermo Fisher Scientific Inc
Global Endocrine Testing Market Segmentation:
Our report has categorized the market based on region, test type, technology and end-use.
By Test Type:
- Thyroid Test
- Insulin Test
- Human Chorionic Gonadotropin Test
- Prolactin Test
- Luteinizing Hormone Test
- Progesterone Test
- Others
By Technology:
- Immunoassay
- Tandem Mass Spectroscopy
- Sensor Technology
- LC-MS
- Others
By End Use:
- Hospitals
- Ambulatory Care Centers
- Clinical Laboratories
- Others
By Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porters Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
